Mankind Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE634S01028
  • NSEID: MANKIND
  • BSEID: 543904
INR
2,162.60
98.8 (4.79%)
BSENSE

Feb 03

BSE+NSE Vol: 7.93 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
3,567.20
3,697.16
3,570.35
3,079.37
3,198.79
3,061.43
2,867.85
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,567.20
3,697.16
3,570.35
3,079.37
3,198.79
3,061.43
2,867.85
Raw Material Cost
553.04
594.36
585.68
554.25
532.40
459.82
469.88
Purchase of Finished goods
411.67
412.97
404.97
411.12
387.30
424.28
432.99
(Increase) / Decrease In Stocks
13.28
54.84
62.94
-89.99
11.81
-11.38
-93.44
Employee Cost
823.71
825.18
783.41
715.80
704.75
642.12
629.70
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
846.07
888.48
886.58
805.00
746.54
699.40
757.16
Total Expenditure (Excl Depreciation)
2,647.77
2,775.83
2,723.58
2,396.18
2,382.80
2,214.24
2,196.29
Operating Profit (PBDIT) excl Other Income
919.43
921.33
846.77
683.19
815.99
847.19
671.56
Other Income
72.75
91.87
79.88
251.33
77.00
109.06
99.40
Operating Profit (PBDIT)
992.18
1,013.20
926.65
934.52
892.99
956.25
770.96
Interest
157.20
169.68
170.65
190.54
220.93
7.10
10.84
Exceptional Items
-106.59
0.00
0.00
-4.34
6.65
-2.37
4.59
Gross Profit (PBDT)
728.39
843.52
756.00
743.98
672.06
949.15
760.12
Depreciation
222.60
221.82
218.68
230.87
187.17
100.49
102.69
Profit Before Tax
509.00
624.02
540.49
515.43
488.33
851.23
661.34
Tax
95.12
103.84
95.87
86.44
110.46
189.98
122.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
410.67
517.86
441.45
426.67
374.43
658.68
534.57
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
-4.34
6.65
-2.37
4.59
Net Profit
410.67
517.86
441.45
422.33
381.08
656.31
539.16
Share in Profit of Associates
3.21
2.32
3.17
2.32
3.44
2.57
3.91
Minority Interest
5.13
8.67
6.30
3.88
4.29
5.41
6.58
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
408.75
511.51
438.32
420.77
380.23
653.47
536.49
Equity Capital
41.28
41.28
41.26
41.26
41.26
40.06
40.06
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
9.9
12.39
10.62
10.2
9.22
16.31
13.39
Diluted Earnings per share
9.89
12.38
10.6
10.18
9.44
16.28
13.37
Operating Profit Margin (Excl OI)
25.77%
24.92%
23.72%
22.19%
25.51%
27.67%
23.42%
Gross Profit Margin
20.42%
22.82%
21.17%
24.16%
21.01%
31.0%
26.5%
PAT Margin
11.6%
14.07%
12.45%
13.93%
11.81%
21.6%
18.78%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is -3.52% vs 3.55% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -20.09% vs 16.70% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -0.21% vs 8.81% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -7.36% vs -0.57% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Mankind Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
3,567.20
6,123.20
-2,556.00
-41.74%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,567.20
6,123.20
-2,556.00
-41.74%
Raw Material Cost
553.04
1,327.10
-774.06
-58.33%
Purchase of Finished goods
411.67
589.10
-177.43
-30.12%
(Increase) / Decrease In Stocks
13.28
-225.70
238.98
105.88%
Employee Cost
823.71
1,034.20
-210.49
-20.35%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
846.07
1,382.70
-536.63
-38.81%
Total Expenditure (Excl Depreciation)
2,647.77
4,107.40
-1,459.63
-35.54%
Operating Profit (PBDIT) excl Other Income
919.43
2,015.80
-1,096.37
-54.39%
Other Income
72.75
109.00
-36.25
-33.26%
Operating Profit (PBDIT)
992.18
2,124.80
-1,132.62
-53.30%
Interest
157.20
101.30
55.90
55.18%
Exceptional Items
-106.59
-34.20
-72.39
-211.67%
Gross Profit (PBDT)
728.39
1,989.30
-1,260.91
-63.38%
Depreciation
222.60
301.90
-79.30
-26.27%
Profit Before Tax
509.00
1,687.40
-1,178.40
-69.84%
Tax
95.12
454.00
-358.88
-79.05%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
410.67
1,233.40
-822.73
-66.70%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
410.67
1,233.40
-822.73
-66.70%
Share in Profit of Associates
3.21
5.20
-1.99
-38.27%
Minority Interest
5.13
-20.00
25.13
125.65%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
408.75
1,258.60
-849.85
-67.52%
Equity Capital
41.28
100.60
-59.32
-58.97%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
9.90
12.51
-2.61
-20.86%
Diluted Earnings per share
9.89
12.51
-2.62
-20.94%
Operating Profit Margin (Excl OI)
25.77%
33.39%
0.00
-7.62%
Gross Profit Margin
20.42%
32.95%
0.00
-12.53%
PAT Margin
11.60%
20.43%
0.00
-8.83%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3,567.20 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -3.52% vs 3.55% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 11.52% vs 22.70% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 408.75 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -20.09% vs 16.70% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 7.50% vs -16.20% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 919.43 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -0.21% vs 8.81% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 12.68% vs 34.54% in Dec 2024

Quarterly - Interest
Interest 157.20 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -7.36% vs -0.57% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -28.85% vs 2,304.03% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.77%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024